Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $91.34 --0%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
AFIB, VAXX, NMRD, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- X-Energy, Inc. (XE) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
